Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened
These sales were driven by tax withholding obligations tied to restricted stock unit vesting under a pre-established trading plan.
Overview
Thomas Edward Schoenherr, the CEO of diagnostics at Tempus AI, Inc. (NASDAQ:TEM), sold 17,314 shares of Class A Common Stock on August 18 and August 19, according to an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($53.71); post-transaction value based on the August 19 market close ($61.25).
Details
Tempus AI is a healthcare technology company with a $10.7 billion market capitalization and 3,800 employees headquartered in Chicago. The company has established a vertically integrated platform that combines clinical software, diagnostic analytics, and laboratory services to address the precision medicine market, though it remains unprofitable on a TTM basis, with negative net income of $254.4 million, as it invests in platform expansion and market penetration.
Source
Originally published at www.fool.com.